Batabulin Uses, Dosage, Side Effects and more
Batabulin is under investigation in clinical trial NCT00057382 (T138067 Versus Doxorubicin in Chemotherapy-naive, Unresectable, Hepatocellular Carcinoma Patients).
| Trade Name | Batabulin |
| Generic | Batabulin |
| Batabulin Other Names | Batabulin |
| Type | |
| Formula | C13H7F6NO3S |
| Weight | Average: 371.25 Monoisotopic: 371.005083241 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
